Related Experiment Video
Updated: May 1, 2026

Measuring Delay Discounting in Humans Using an Adjusting Amount Task
Published on: January 9, 2016
Advancing the extended parallel process model through the inclusion of response cost measures
Lance S Rintamaki1, Z Janet Yang
1a Department of Communication , University at Buffalo, The State University of New York , Buffalo , New York , USA.
This study enhances the Extended Parallel Process Model by incorporating response costs, improving its ability to predict health behaviors like condom use for sexually transmitted infections (STIs). The findings support including these drawbacks in health communication models.
Area of Science:
- Health Communication
- Behavioral Science
- Psychology
Background:
- The Extended Parallel Process Model (EPPM) explains how individuals respond to health threats.
- Existing models may not fully account for the perceived drawbacks of recommended health behaviors.
Purpose of the Study:
- To advance the Extended Parallel Process Model (EPPM) by integrating response cost measures.
- To examine the role of response costs in condom use intentions and perceptions of sexually transmitted infections (STIs).
Main Methods:
- A survey of 502 college students assessed perceptions of STI risks and condom use.
- Participants read information from the CDC on STIs and condom efficacy.
- Hierarchical ordinary least squares regression was used to analyze the data.
Main Results:
- Response cost measures significantly improved the predictive power of the Extended Parallel Process Model (EPPM).
- Perceived drawbacks associated with condom use influenced behavioral intentions.
Conclusions:
- Response costs are a valuable addition to the Extended Parallel Process Model (EPPM).
- Understanding and addressing perceived response costs can enhance health communication strategies for STI prevention.
Related Concept Videos
Pharmacodynamic Models: Direct Effect Model and Indirect Response Model
Response Surface Methodology
The process of RSM involves several key steps:
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Methods of Medium Optimization
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model
Scale-Up Processes

